OneMedNet Reports Over 25% Expansion of iRWD鈩� Network, Encompassing Clinical Data alongside Aggregate Health Economics and Social Determinant Insights from 5 Billion Administrative Records, Fueling Growth in AI-Powered Healthcare Data
OneMedNet (NASDAQ:ONMD), a leader in AI-powered AG真人官方-World Data (RWD), has announced a 25% expansion of its iRWD鈩� network and platform. The company now encompasses 1,750+ healthcare system partner sites, providing access to 34 million patients, 136 million clinical exams, and 5 billion administrative records.
The expansion significantly enhances OneMedNet's capability to provide insights into rare diseases, underserved populations, and health economics. Operating in the $60 billion RWE industry, the company is positioned for accelerated revenue growth through increased data licensing and new enterprise partnerships.
OneMedNet (NASDAQ:ONMD), leader nell'utilizzo dell'intelligenza artificiale per i dati reali (RWD), ha annunciato un'espansione del 25% della sua rete e piattaforma iRWD鈩�. L'azienda ora include oltre 1.750 siti partner di sistemi sanitari, offrendo accesso a 34 milioni di pazienti, 136 milioni di esami clinici e 5 miliardi di registri amministrativi.
Questa espansione potenzia notevolmente la capacit脿 di OneMedNet di fornire approfondimenti sulle malattie rare, sulle popolazioni meno servite e sull'economia sanitaria. Operando in un settore del RWE da 60 miliardi di dollari, l'azienda 猫 ben posizionata per una crescita accelerata dei ricavi grazie a un aumento delle licenze dati e nuove partnership aziendali.
OneMedNet (NASDAQ:ONMD), l铆der en datos del mundo real (RWD) impulsados por IA, ha anunciado una expansi贸n del 25% de su red y plataforma iRWD鈩�. La compa帽铆a ahora incluye m谩s de 1.750 sitios asociados en sistemas de salud, proporcionando acceso a 34 millones de pacientes, 136 millones de ex谩menes cl铆nicos y 5 mil millones de registros administrativos.
Esta expansi贸n mejora significativamente la capacidad de OneMedNet para ofrecer informaci贸n sobre enfermedades raras, poblaciones desatendidas y econom铆a de la salud. Operando en una industria de RWE de 60 mil millones de d贸lares, la empresa est谩 posicionada para un crecimiento acelerado de ingresos mediante el aumento de licencias de datos y nuevas asociaciones empresariales.
OneMedNet (NASDAQ:ONMD)鞚� AI 旮半皹 鞁れ牅 雿办澊韯�(RWD) 攵勳暭鞚� 靹犽弰 旮办梾鞙茧, iRWD鈩� 雱ろ姼鞗岉伂 氚� 頂岆灚韽检潉 25% 頇曥灔頄堧嫟瓿� 氚滍憸頄堨姷雼堧嫟. 順勳灛 須岇偓電� 1,750臧� 鞚挫儊鞚� 鞚橂 鞁滌姢韰� 韺岉姼雱� 靷澊韸�毳� 韽暔頃橂┌, 3,400毵� 氇呾潣 頇橃瀽, 1鞏� 3,600毵� 瓯挫潣 鞛勳儊 瓴�靷�, 50鞏� 瓯挫潣 頄夓爼 旮半鞐� 鞝戧芳頃� 靾� 鞛堨姷雼堧嫟.
鞚措矆 頇曥灔鞚� 頋穩歆堩櫂, 靻岇櫢霅� 鞚戈惮, 瓯搓皶 瓴届牅鞐� 雽�頃� 鞚胳偓鞚错姼 鞝滉车 電ル牓鞚� 韥矊 頄レ儊鞁滌及鞀惦媹雼�. 600鞏� 雼煬 攴滊鞚� RWE 靷办梾鞐愳劀 頇滊彊頃橂姅 鞚� 須岇偓電� 雿办澊韯� 霛检澊靹犾姢 頇曤寑鞕� 鞁犼窚 旮办梾 韺岉姼雱堨嫮鞚� 韱淀暣 毵れ稖 靹膘灔鞚� 臧�靻嶍檾頃� 鞙勳箻鞐� 鞛堨姷雼堧嫟.
OneMedNet (NASDAQ:ONMD), leader dans les donn茅es du monde r茅el (RWD) aliment茅es par l'IA, a annonc茅 une expansion de 25% de son r茅seau et de sa plateforme iRWD鈩�. L'entreprise compte d茅sormais plus de 1 750 sites partenaires de syst猫mes de sant茅, offrant un acc猫s 脿 34 millions de patients, 136 millions d'examens cliniques et 5 milliards de dossiers administratifs.
Cette expansion renforce consid茅rablement la capacit茅 de OneMedNet 脿 fournir des informations sur les maladies rares, les populations mal desservies et l'茅conomie de la sant茅. Op茅rant dans une industrie du RWE de 60 milliards de dollars, la soci茅t茅 est bien positionn茅e pour une croissance acc茅l茅r茅e de ses revenus gr芒ce 脿 une augmentation des licences de donn茅es et de nouveaux partenariats d'entreprise.
OneMedNet (NASDAQ:ONMD), ein f眉hrendes Unternehmen im Bereich KI-gest眉tzter AG真人官方-World-Daten (RWD), hat eine 25%ige Erweiterung seines iRWD鈩� Netzwerks und seiner Plattform angek眉ndigt. Das Unternehmen umfasst nun 眉ber 1.750 Partnerstandorte im Gesundheitswesen und bietet Zugang zu 34 Millionen Patienten, 136 Millionen klinischen Untersuchungen und 5 Milliarden Verwaltungsdatens盲tzen.
Die Erweiterung verbessert die F盲higkeit von OneMedNet erheblich, Einblicke in seltene Krankheiten, unterversorgte Bev枚lkerungsgruppen und Gesundheits枚konomie zu liefern. Das Unternehmen ist im 60-Milliarden-Dollar-RWE-Markt t盲tig und positioniert sich f眉r ein beschleunigtes Umsatzwachstum durch erweiterte Datenlizenzen und neue Unternehmenspartnerschaften.
- 25% expansion of iRWD鈩� network reaching 1,750+ healthcare system sites
- Massive data scale with 136 million clinical exams and 5 billion administrative records
- Enhanced coverage of rare diseases and underserved populations
- Strong positioning in the $60 billion RWE industry
- None.
Insights
OneMedNet's 25% network expansion significantly enhances its real-world data capabilities, strengthening its competitive position in the growing $60B RWE market.
OneMedNet has achieved a substantial
This expansion directly addresses several high-value market needs: longitudinal patient data, rare disease insights, and comprehensive datasets that include both clinical and economic factors. By incorporating data from underserved populations, OneMedNet is positioning itself to serve researchers focused on health equity 鈥� an increasingly important area in healthcare analytics.
From a business perspective, this network expansion creates multiple revenue acceleration opportunities. The substantially larger data pool enhances OneMedNet's value proposition to life sciences companies, payers, and healthcare innovators who rely on real-world evidence for research, development, and strategic decision-making. The timing is particularly advantageous as OneMedNet reports the RWE industry is valued at approximately
The combination of clinical depth and administrative breadth differentiates OneMedNet in the competitive healthcare data market. While many competitors offer either clinical or administrative data, OneMedNet's integrated approach provides a more comprehensive view of patient journeys, treatment patterns, and outcomes 鈥� exactly the type of multi-dimensional data that commands premium pricing in today's market.
This expansion represents not just incremental growth but a strategic positioning that could translate to accelerated revenue through both expanded data licensing opportunities and new enterprise partnerships, potentially establishing OneMedNet as a more significant player in the rapidly evolving healthcare data analytics landscape.
Over 1,750 provider sites and access to 136 million clinical exams positions OneMedNet for accelerated revenue and market penetration
MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (鈥淥neMedNet鈥� or the 鈥淐ompany鈥�), a leader in AI-powered AG真人官方-World Data (RWD) announced today a greater than
Driven by the rising demand for high-quality longitudinal data, rare disease insights, and datasets that include health economics and social determinants of health, OneMedNet has rapidly accelerated the development of new partner sites across its nationwide network. This expansion also responds to the growing need for inclusive data representing underserved and underrepresented populations.
As a result, OneMedNet now provides its customers with seamless access to a dramatically scaled, de-identified data network comprising the following key growth metrics:
25% iRWD鈩� network expansion- 1750+ healthcare system and provider partner sites
- 34 million patients
- 136 million clinical exams
- 5 billion Administrative Records, inclusive of claims
- Addresses rare diseases, underserved populations, and high-demand RWD sectors by enabling insights into health economic and social determinants
- Poised for significant revenue growth through increased data licensing and new enterprise partnerships
This exponential growth not only reinforces OneMedNet鈥檚 position as a premier data partner but also lays the foundation for accelerated revenue generation, customer acquisition, and data monetization at scale.
At OneMedNet, we believe AG真人官方-World Evidence is only as powerful as the clinical integrity of the data behind it. The OneMedNet iRWD鈩� network and platform delivers regulatory-grade depth and precision, enabling life sciences, payers, and healthcare innovators to generate clinically grounded insights that are actionable and reflective of how care is delivered in the real world. As the
About OneMedNet Corporation
OneMedNet is revolutionizing how the world unlocks AG真人官方-World Data (RWD), harnessing the untapped potential of over 1,750 healthcare sites through its iRWD鈩� platform. This isn鈥檛 just data鈥攊t鈥檚 the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.
Beyond healthcare OneMedNet鈥檚 proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities鈥攔igorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at .
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as 鈥渕ay,鈥� 鈥渟hould,鈥� 鈥渆xpects,鈥� 鈥渁nticipates,鈥� 鈥渃ontemplates,鈥� 鈥渆stimates,鈥� 鈥渂elieves,鈥� 鈥減lans,鈥� 鈥減rojected,鈥� 鈥減redicts,鈥� 鈥減otential,鈥� or 鈥渉opes鈥� or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Bitcoin, including Bitcoin鈥檚 volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.
OneMedNet Contacts:
Michael Wong, VP Marketing
Email: [email protected]
SOURCE: ONEMEDNET CORPORATION
FAQ
What is the size of OneMedNet's (ONMD) iRWD鈩� network after the recent expansion?
How many administrative records does OneMedNet (ONMD) now have access to?
What is the market size for AG真人官方-World Evidence (RWE) industry where OneMedNet operates?
How does OneMedNet's expansion impact its revenue potential?
What types of healthcare data does OneMedNet's iRWD鈩� network provide?
